To establish the role of MIF in human KMT2A-R leukemia, we determined its expression in infant KMT2A-AFF1-rearranged ALL, showing that MIF was significantly higher expressed in patients with activating mutations (Fig. 5c)4. Here, KMT2A is linked to acute lymphoblastic leukemia.